KI 8110: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 3081597 |
MeSH ID | M0137661 |
Synonym |
---|
80681-73-8 |
uridine, 5'-o-(n-acetyl-4,7,8,9-tetra-o-acetyl-1-methyl-alpha-neuraminosyl)-5-fluoro-2',3'-o-(1-methylethylidene)- |
5-fluoro-2',3'-isopropylidene-5'-o-(4-n-acetyl-2,4-dideoxy-3,6,7,8-tetra-o-acetyl-1-methoxycarbonylglycerogalactooctapyranosyl)uridine |
ki-8110 |
ki 8110 |
methyl (2r,4s,5r,6r)-2-[[(3ar,4r,6r,6ar)-4-(5-fluoro-2,4-dioxopyrimidin-1-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxy]-5-acetamido-4-acetyloxy-6-[(1s,2r)-1,2,3-triacetyloxypropyl]oxane-2-carboxylate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.74) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |